Concepedia

Laura Guantay

LG

Statistics

Publications

3

Citations

74

H-Index

3

Active since

2019

Affiliations

Research Centre in Biological Chemistry of Córdoba(Current)

Universidad Nacional de Córdoba

Fundación Instituto Leloir

GlaxoSmithKline (United Kingdom)

Providence College

Laura Guantay is an author at Research Centre in Biological Chemistry of Córdoba specializing in apoptosis, oncology, and kinase inhibitors.

Publications per year

2019–2023

3

Publications

3

Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction

Sofía Carbajosa, María Florencia Pansa, Natalia S. Paviolo et al. · Clinical Cancer Research · 2019 · 36 citations · Full text

, , +16

AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress

Florencia Villafañez, Iris Alejandra García, Sofía Carbajosa et al. · Oncogene · 2019 · 28 citations · Full text

, , +17

Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency

Laura Guantay, Cintia Garro, Sebastián Omar Siri et al. · Drug Resistance Updates · 2023 · 10 citations

, , +12

1–3 of 3